Identification and validation of serum MUC17 as a non‐invasive early warning biomarker for screening of gastric intraepithelial neoplasia
These findings suggest that plasma MUC17 levels hold substantial promise as a screening biomarker for individuals with GIN and EGC, effectively identifying high-risk groups that necessitate further gastroscopy.
Authors
- Zhijie Feng (ORCID: https://orcid.org/0009-0006-7980-2373)
- Xiuhong Huang (ORCID: https://orcid.org/0000-0002-8788-3314)
- Yujian He
- Bingxue Yang
- Chenguang Ji
- Xiaoxu Jin
- Li Liu
- Kaige Yin
- Xiao‐Li Xie
Institutions
- Hebei Medical University (CN)
- Second Hospital of Hebei Medical University (CN)
Publication Details
- Journal
- Translational Oncology
- Published
- 2024-11-23
- DOI
- https://doi.org/10.1016/j.tranon.2024.102207
- Citations
- 4
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.68
Funders
- Natural Science Foundation of Hebei Province